This past spring KSM-66 Advanced Ashwagandha received recognition at two of the nutrition industry's largest trade shows. Its first award as "Innovative Ingredient of the Year" was given at Panacea, South Asia's largest trade show and conference for nutrition products held in Mumbai, India. KSM-66 was further recognized at Engredea as part of the Expo West trade show in Anaheim, California, as a finalist for the "Best Botanical" award. Both award selection processes included reviews by key industry experts and influencers.
"We're excited that industry leaders have validated our dedication for introducing KSM-66 on a science-based, sustainable platform," said Kartikeya Baldwa, director for Ixoreal Biomed. "KSM-66 has been clinically studied in humans and offers distinct advantages such as its high potency and consistency."
Ixoreal Biomed is the only ashwagandha manufacturer in the world to own the entire value chain for producing the extract. Ixoreal Biomed has its own farms, production facilities, testing laboratories, research and distribution. As a result, Ixoreal Biomed can ensure batch-to-batch consistency and maintain a cost-effective, reliable supply base.
KSM-66 has been evaluated in five scientific studies with an additional two studies ongoing. These studies define the role of KSM-66 as an adaptogen for healthy stress management where it exhibits a normalizing effect against common physical, chemical and biological stressors. The first of these studies will be published by the Indian Journal of Psychiatry and investigated the efficacy of KSM-66 in 64 healthy adults who were under stress. The remaining studies examined KSM-66 and its stress-reducing properties related to energy, infertility, immunity, longevity, cognitive function and physical performance.